for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

IPCA Laboratories Ltd

IPCA.NS

Latest Trade

882.50INR

Change

-7.55(-0.85%)

Volume

430,945

Today's Range

861.10

 - 

890.00

52 Week Range

631.00

 - 

1,046.00

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Pricing

Previous Close
890.05
Open
886.25
Volume
430,945
3M AVG Volume
3.61
Today's High
890.00
Today's Low
861.10
52 Week High
1,046.00
52 Week Low
631.00
Shares Out (MIL)
126.35
Market Cap (MIL)
112,459.70
Forward P/E
19.34
Dividend (Yield %)
0.34

Next Event

IPCA Laboratories Ltd Extraordinary Shareholders Meeting

Latest Developments

More

IPCA Laboratories Re-Appoints Ajit Kumar Jain As Joint MD For 5 Years

India's IPCA Laboratories June-Qtr Consol Net Profit Rises

India's IPCA Laboratories March Quarter Profit From Cont Ops Rises

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About IPCA Laboratories Ltd

Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs). It offers APIs, such as atenolol, hydroxychloroquine sulfate, morantel citrate, pyrantel pamoate and zaltoprofen. It offers brands, such as Zerodol, Lariago, HCQS Perinorm, Rapither, Tenoric, Lumerax, Etova, Malirid and Folitrax. Its 3c division focuses on cardiovascular and anti-diabetic markets. Its 3d division is focused on cardio-diabetic market. The Company's activa division serves the rheumatology market. Its altus division caters to the needs of intensivists, both surgical and non-surgical. Its Bionova division's focus area is dermatology. Its dynamix division focuses on cardiovascular, gastro-intestinal, anti-bacterial, pain management and respiratory sectors. It hycare division caters to the needs of cardiologists and diabetologists. Its divisions also include innova, intima, pain management, pharma and uro sciences.

Industry

Biotechnology & Drugs

Contact Info

142 AB, Kandivli Industrial Estate

Kandivli (West)

+91.22.66474747

http://www.ipcalabs.com

Executive Leadership

Premchand Godha

Executive Chairman of the Board, Chief Executive Officer, Managing Director

Ajit Kumar Jain

Chief Financial Officer, Joint Managing Director, Executive Director

E. J. Babu

President - API Exports

Sunil Ghai

President - Domestic Marketing

N. Guhaprasad

President - International Marketing (Branded Formulations)

Key Stats

1.96 mean rating - 23 analysts
Sell
Hold
Buy
Revenue (MM, INR)

2017

32.1K

2018

32.8K

2019

37.7K

2020(E)

42.7K
EPS (INR)

2017

15.420

2018

18.970

2019

35.010

2020(E)

44.549
Price To Earnings (TTM)
22.23
Price To Sales (TTM)
2.83
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
16.76
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

BRIEF-India's IPCA Labs Dec-Qtr Profit More Than Doubles

* DEC QUARTER PROFIT FROM CONTINUING OPERATIONS 1.06 BILLION RUPEES VERSUS PROFIT 413.8 MILLION RUPEES YEAR AGO

BRIEF-Ipca Laboratories' Units To Acquire Pisgah Labs For $9.65 Mln​​

* SAYS ACQUISITION OF 100 PCT SHARE CAPITAL OF PISGAH LABS INC., NORTH CAROLINA, USA BY COMPANY'S SUBSIDIARIES

BRIEF-India's IPCA Labs Sept-qtr profit up about 76 pct

* Sept quarter profit from continuing operations 964.7 million rupees versus profit of 549.5 million rupees last year

BRIEF-Ipca Labs says The ‍global Fund selected co as panel supplier of anti-malarial medicines

* The global Fund selected co as panel supplier of anti-malarial medicines Source text - http://bit.ly/2zwhueB Further company coverage:

BRIEF-India's Ipca Laboratories posts June-qtr loss

* June quarter loss from continuing operations 202.5 million rupees versus profit of 475.7 million rupees last year

BRIEF-Ipca Labs Dec-qtr profit up about 57 pct

* Dec quarter total income from perations 7.51 billion rupees

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up